Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison Between Erythropoietin and Erythropoietin Associated to Differentiating Therapy With Acid 13-cis-retinoic and Dihydroxyvitamin D3 in Myelodysplastic Syndromes Without Excess of Blasts

NCT00804050 is registered in ClinicalTrials.gov with Fondazione Italiana Sindromi Mielodisplastiche-ETS as lead sponsor.

NCT NCT00804050
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00804050 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison Between Erythropoietin and Erythropoietin Associated to Differentiating Therapy With Acid 13-cis-retinoic and Dihydroxyvitamin D3 in Myelodysplastic Syndromes Without Excess of Blasts
Lead sponsor
Fondazione Italiana Sindromi Mielodisplastiche-ETS
Phase
Phase 3
Overall status
Terminated
Start date
March 31, 2007
Completion date
March 31, 2010
Enrollment
184 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

myelodysplastic syndromes